Image quality and safety in pediatric urography using an ionic and a non-ionic iodinated contrast agent

Area of Science:

• Radiology
• Pediatric Imaging
• Contrast Media

Background:

• Ionic contrast media have been standard for pediatric urography.
• Evaluating newer, potentially safer contrast agents is crucial for improving diagnostic procedures.
• Non-ionic, monomeric contrast media offer potential advantages in safety profiles.

Purpose of the Study:

• To compare the safety and diagnostic efficacy of iopentol (Imagopaque) versus metrizoate (Isopaque) in pediatric urography.
• To assess adverse event profiles and diagnostic image quality between the two contrast agents.
• To evaluate the impact of contrast media on serum chemistry in pediatric patients.

Main Methods:

• A randomized, double-blind, parallel study involving 59 children (3 months to 8 years) without risk factors.
• Assessment of diagnostic efficacy based on renal/perirenal tissue attenuation differences and subjective evaluation of anatomical structures.
• Monitoring of adverse events and serum chemistry changes post-contrast medium injection.

Main Results:

• No statistically significant difference in diagnostic efficacy between iopentol and metrizoate groups.
• Significantly fewer mild to moderate transient adverse events observed in the iopentol group compared to the metrizoate group.
• No clinically significant changes in serum chemistry variables were noted for either contrast medium.

Conclusions:

• Iopentol is a safe and effective alternative to metrizoate for urography in children.
• The improved safety profile of iopentol, with fewer adverse events, is a significant benefit.
• Both contrast media demonstrated adequate diagnostic performance without impacting key serum chemistry parameters.